Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Loading stockData sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Not financial advice. Analytical data for research only.
Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.
Akzo Nobel N.V. is a Dutch multinational corporation and one of the world's leading producers of paints, performance coatings, and specialty chemicals. Formed in 1994 through the merger of Akzo and Nobel Industries, the company, headquartered in Amsterdam, Netherlands, operates in over 150 countries with approximately 34,600 employees. It serves diverse sectors including construction, automotive, aerospace, marine, energy, packaging, infrastructure, agriculture, and consumer goods, offering products such as decorative paints under brands like Dulux and Sikkens, alongside marine and protective coatings, automotive and specialty coatings, industrial coatings, and powder coatings. Akzo Nobel N.V. emphasizes sustainability, integrating environmental responsibility into its operations to minimize impact while driving innovation in durable, eco-friendly solutions. Recognized as the third-largest paint manufacturer globally by revenue, it plays a pivotal role in enhancing and protecting surfaces across industries, from everyday homes to critical infrastructure, contributing significantly to the global coatings market through its commitment to quality and technological advancement.
€58.24
+€0.34 (+0.59%)
EOD Sep 11, 2026
11.46% operating margin is respectable but not wide. ROIC at 7.89%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue declined 5.2% YoY. The question is whether this is cyclical or a structural shift.
Net debt of €2.94B represents 4.9x FCF, leverage limits flexibility.
16.1x earnings, 15.5x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
€9.93B
▼ -5.2% YoY
Net Income (TTM)
€651M
▲ +13.3% YoY
Op. Margin
11.57%
▲ +2.9pp YoY
ROIC
7.89%
▲ +1.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
€645M
▲ +65.1% YoY
Op. Cash Flow (TTM)
€661M
▲ +56.2% YoY
Net Debt
€2.94B
Cash & Equiv.
€1.92B
3Y CAGR: -2.2%
Continue Research
At a P/E of 16.1 and a price-to-free-cash-flow of 15.5, Akzo Nobel NV (AKZA.XAMS) trades below a two-stage DCF intrinsic value of about €127.51 per share, so at €58.24 the stock looks undervalued (118.9% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Akzo Nobel NV scores 48/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 3.8%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about €127.51 per share for AKZA.XAMS, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around €95.64. At today's €58.24, that puts the stock about 118.9% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Akzo Nobel NV scores 48 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 11.6% operating margin and a 7.9% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Akzo Nobel NV pays a regular dividend of about €2.21 per share per year (typically in quarterly installments), a yield of roughly 3.8% at the current price. That is a payout ratio of about 58.2% of earnings, so the dividend is well covered. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For AKZA.XAMS's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. AKZA.XAMS currently trades below its estimated intrinsic value and scores 48/100 on quality (mixed). It also yields about 3.8%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.